Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-10
2007-07-10
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S254020, C514S254040, C514S249000, C514S253060, C544S121000, C544S368000, C544S356000, C544S360000, C544S364000
Reexamination Certificate
active
11291216
ABSTRACT:
The present invention relates to compounds of the general formula IwhereinR1is the groupand R2, R′, R″, R3, R4, R5, R6, R7, X1, X1′, X2, and N are as defined in the specification. Compounds of the invention are useful for the treatment of neurological and neuropsychiatric disorders.
REFERENCES:
patent: 3933802 (1976-01-01), Ferrini et al.
patent: 4244871 (1981-01-01), Kosary et al.
patent: 2005/0059668 (2005-03-01), Alberati-Giani et al.
patent: 2005/0070539 (2005-03-01), Alberati-Giani et al.
patent: 2005/0209241 (2005-09-01), Jolidon et al.
patent: 0 171 636 (1985-02-01), None
patent: 0 624 584 (1994-11-01), None
patent: 2 861 073 (2005-04-01), None
patent: WO 99/44596 (1999-09-01), None
patent: WO 99/45011 (1999-09-01), None
patent: WO 01/81308 (2001-11-01), None
patent: WO 02/22612 (2002-03-01), None
patent: WO 03/004480 (2003-01-01), None
patent: WO 03/010132 (2003-02-01), None
patent: WO 03/035602 (2003-05-01), None
patent: WO 2004/037800 (2004-05-01), None
patent: WO 2004/072034 (2004-08-01), None
patent: WO 2004/113280 (2004-12-01), None
patent: WO 2005/023260 (2005-03-01), None
patent: WO 2005/103042 (2005-11-01), None
patent: WO 2005/110983 (2005-11-01), None
Lewis D.A. & Lieberman J.A., Neuron. vol. 28, pp. 325-334 (2000).
Vandenberg R. J. & Aubrey K. R., Exp. Opin. Ther. Targets vol. 5(4) pp. 507-518 (2001).
Nakazato A. & Okuyama S., Exp. Opin. Ther. Patents vol. 10(1) pp. 75-98 (2000).
Sharma T., Br. J. Psychiatry, vol. 174 (Suppl. 38) pp. 44-51 (1999).
Javitt D. C. et al., Biol. Psychiatry, vol. 45 pp. 668-679 (1999).
Mohn A. R., Cell vol. 98 pp. 427-436 (1999).
Bliss, T. V. & Collingridge G. L., Nature, vol. 361 pp. 31-39 (1993).
Tang J. P. et al., Nature, vol. 401, pp. 63-69 (1999).
Gainetdinov R. R. et al., Trends in Pharm. Sci. vol. 23(8) pp. 367-373 (2002).
Lopez-Corcuera B, et al., Mol. Mem. Biol. vol. 18 pp. 13-20 (2001).
Bergeron R. et al., Proc. Natl. Acad. Sci. USA vol. 95, pp. 15730-15734 (1998).
Chen et al., J. Neurophysiol. vol. 89(2) pp. 691-703 (2003).
Armer R. E. & Miller D. J., Exp. Opin. Ther. Patents vol. 11(4) pp. 563-572 (2001).
Pralong E. et al., Prog. in Neurobiol. vol. 67, pp. 173-202 (2002).
Carlsson M. L., J. Neural Trans. vol. 105, pp. 525-535 (1998).
Kwong et al., Org. Lett. 4, pp. 581-584 (2002).
Kuwano et al., JOC 67, pp. 6479-6486 (2002).
Chem. Abstract XP-002299148 Chemcats No. 2004:3653471 (2004).
Caulfield W. L. et al., Journal of Med. Chem. vol. 44(17) pp. 2679-2682 (2001).
Chem. Abstract XP-002299149 Chemcats No. 2004: 2179871 (2004).
Chemical Abstracts Service, Apr. 23, 2003, XP002308402, Database accession No. 2003: 2142911 Chemcats & Catalog: AsInExExpress Gold.
Chemical Abstracts Service, Jun. 6, 2003, XP002308481 & Database Chemcats.
Chemical Abstracts Service, Jan. 1, 2004, XP002308405, Database accession No. 2003:2872406 Chemcats & Catalog: Ambinter Stock Screening Collection.
Chemical Abstracts Service, Jan. 1, 2004, XP002308403, Database accession No. 2004:591813 & Catalog: Ambinter Stock Screening Collection.
Chemical Abstracts Service, Jan. 1, 2004, XP002308404, Database accession No. 2004:660630 & Catalog: Ambinter Screening Library.
Chemical Abstracts Service, XP002308978 Chemcats No. 2002:330684 (2003).
Chemical Abstracts Service, XP002308979; CHEMCATS No. 2003:1026314 (2004)
Chemical Abstracts Service, XP002308980; CHEMCATS No. 2001;2814605 (2003).
Chemical Abstracts Service, XP002308981; CHEMCATS No. 2002:2063001 (2004).
Chemical Abstracts Service, XP002308983; CHEMCATS No. 2003:1026533 (2004).
Chemical Abstracts Service, XP002308984; CHEMCATS No. 2002:2288893 (2004).
Chemical Abstracts Service, XP002308985; CHEMCATS No. 2003:709504 (2004).
Chemical Abstracts Service, XP002308986; CHEMCATS No. 2003:709503 (2004).
Chemical Abstracts Service, XP002308987; CHEMCATS No. 2003:709505 (2004).
Chemical Abstracts Service, XP002308988; CHEMCATS No. 2004:1498769 (2004).
Chemical Abstracts Service, XP002308989; CHEMCATS No. 2002:2386068 (2004).
Chemical Abstracts Service, XP002308990; CHEMCATS No. 2002:2894607 (2004).
Chemical Abstracts Service, XP002308991; CHEMCATS No. 2003:3342164 (2004).
Chemical Abstracts Service, XP002308992; CHEMCATS No. 2003:3345505 (2004).
Chemical Abstracts Service, XP002308993; CHEMCATS No. 2003:3346187 (2004).
Chemical Abstracts Service, XP002309007; CHEMCATS No. 2004:660630 (2004).
Abstract corresponding to Document B5—WO 03/035602 (2003).
Jolidon Synese
Narquizian Robert
Norcross Roger David
Pinard Emmanuel
Bernhardt Emily
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Phenyl-piperazine methanone derivatives, substituted by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl-piperazine methanone derivatives, substituted by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl-piperazine methanone derivatives, substituted by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3820454